David Gorden
Associate Program Director · Vanderbilt University Medical Center
Credentials: · · · ·
History
- 1999–2000
- 1992–1994
- 1990–1991
- 1982–1986
Research
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Journal of Lipid Research · 2015 · First of 33 authors · 314 citations
Role of beta-arrestin 1 in the metastatic progression of colorectal cancer
Proceedings of the National Academy of Sciences of the United States of America · 2006 · 228 citations
Antimetastatic role of Smad4 signaling in colorectal cancer
Gastroenterology · 2010 · 185 citations
- RC
14 papers
- CP
10 papers
- JW
10 papers
4 papers · 4 as a resident
3 papers
3 papers · 3 as a resident
- DS
2 papers
- EC
2 papers · 2 as a resident
Grants
- 2009–2015
Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment
National Cancer Institute · U01
Contact PI · $1.4M · Vanderbilt University
- 2007–2012
Multiphoton Microscopy Of Early Tumor/Stromal Interactions In Liver Metastasis
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $152K · Vanderbilt University
- 2004–2010
Role of Metalloproteinases in Colon Cancer Metastases
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $621.3K · Vanderbilt University
Clinical trials
- 2014–2015
3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Principal investigator · Terminated
Vanderbilt-Ingram Cancer Center